Tezepelumab for asthma attacks in the emergency room
Treatments studied
Part of Immune system & allergy, Lungs & breathing clinical trials.
This trial tests if a drug called Tezepelumab can help adults with asthma who visit the emergency room. It aims to reduce severe asthma attacks and improve breathing control.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 18 and 55 years old
- A doctor has told you that you have asthma
- You have been using a high-dose inhaler (like Flovent) plus another asthma controller medication for at least 3 months
- You have had at least one moderate or severe asthma attack in the last year
- If you are a woman who can get pregnant, you must have a negative pregnancy test and use effective birth control during and for 3 months after the study
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests a drug called tezepelumab for people with severe asthma that is not well controlled with current treatments. It aims to see if adding this drug can reduce asthma attacks and improve symptoms.
This study tests whether a physical activity program can help people with severe asthma achieve better control and reduce flare-ups when added to a new treatment called tezepelumab.
This study looks at whether tezepelumab, a biologic medication, can help people with allergic bronchopulmonary aspergillosis (ABPA) and severe asthma. It aims to reduce asthma attacks and improve breathing.
This trial looks at whether people with severe asthma who are taking the biologic tezepelumab can safely reduce their use of inhaled corticosteroids (ICS). It aims to see if reducing or stopping ICS affects asthma symptoms or flare-ups.
This trial tests whether adding an allergy immunotherapy tablet (which helps your immune system get used to dust mites) to a biologic treatment (tezepelumab, which reduces airway inflammation) can keep severe asthma under control better than the biologic alone. It may help reduce asthma attacks and improve daily symptoms.
This study tests if tezepelumab can help reduce severe asthma attacks in children ages 5 to 11. It compares the drug to a placebo (a dummy treatment) to see if it is safe and effective.
Hear when a new Severe Asthma trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.